The Allstate Corporation (ALL · NYSE)

Allstate shares have fallen 15.0% over the past month to $223.74, with RSI(14) at 10 and the stock 7.2% below its 20-day SMA, though it remains roughly flat versus its 200-day SMA (+0.3%). Fundamentals have been strong: the company beat estimates in all of its last four quarters, most recently reporting $8.99 versus $5.76 expected, with earnings up 61.2% year over year on 11.8% revenue growth and ROE of 46.1%. Leverage is modest at 0.4x debt/EBITDA with $2.59B in quarterly free cash flow, and the stock trades at a P/E of 4.48 against an analyst target of $273.68. Piper Sandler reiterated an Overweight rating with a $300 target on October 1, calling the selloff an entry point.